NCT02784808View on ClinicalTrials.gov

Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs)

CompletedOBSERVATIONAL
Enrollment

4,557

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Juvenile Idiopathic Arthritis
Interventions
DRUG

Biological DMARDs

Participants will receive biologic DMARDs as per standard of CARE. The choice of specific biologic DMARD will be at the descretion of treating physician.

DRUG

Non-Biologic DMARDs

Participants will receive non-biologic DMARDs as per standard of care. The choice of specific non-biologic DMARD will be at the descretion of treating physician.

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02784808 - Retrospective Analysis of Pulmonary Arterial Hypertension (PAH) and Related Complications in Juvenile Idiopathic Arthritis (JIA) Participants Treated With Biologic and Non-biologic Disease-modifying Anti-rheumatic Drugs (DMARDs) | Biotech Hunter | Biotech Hunter